Developing story — details emerging. Check the source link for the latest updates.
Source: [Seeking Alpha](https://seekingalpha.com/article/4942514-ose-immunotherapeutics-sa-orpof-lusvertikimab-mechanism-and-clinical-progress-in-ulcerative?source=feed_all_articles)